Mind Medicine (MindMed), Inc. (MNMD)
Total Valuation
MNMD has a market cap or net worth of $369.34 million. The enterprise value is $248.87 million.
Market Cap | 369.34M |
Enterprise Value | 248.87M |
Important Dates
The latest earnings date was Monday, May 16, 2022, before market open.
Last Earnings Date | May 16, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
MNMD has 422.44 million shares outstanding. The number of shares has increased by 8.38% in one year.
Shares Outstanding | 422.44M |
Shares Change (YoY) | +8.38% |
Shares Change (QoQ) | -0.03% |
Owned by Insiders (%) | 12.49% |
Owned by Institutions (%) | 12.92% |
Float | 371.68M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 2.70 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | 11.67 |
Quick Ratio | 11.41 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.00 |
Debt / FCF | 0.00 |
Financial Efficiency
Return on equity (ROE) is -61.30%, which is considered low.
Return on Equity (ROE) | -61.30% |
Return on Assets (ROA) | -56.40% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.36M |
Employee Count | 41 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.16M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.86% in the last 52 weeks. The beta is 1.77, so MNMD's price volatility has been higher than the market average.
Beta (1Y) | 1.77 |
52-Week Price Change | -71.86% |
50-Day Moving Average | 0.84 |
200-Day Moving Average | 1.28 |
Average Volume (30 Days) | 2,530,647 |
Short Selling Information
The latest short interest is 38.14 million, so 9.03% of the outstanding shares have been sold short.
Short Interest | 38.14M |
Short % of Shares Out | 9.03% |
Short % of Float | 10.26% |
Short Ratio (days to cover) | 13.77 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -97.42M |
Pretax Income | -97.80M |
Net Income | -96.64M |
EBITDA | -95.20M |
EBIT | -97.41M |
Earnings Per Share (EPS) | -$0.23 |
Balance Sheet
The company has $120.47 million in cash and no debt, giving a net cash position of $120.47 million or $0.29 per share.
Cash & Cash Equivalents | 120.47M |
Total Debt | 0 |
Net Cash | 120.47M |
Net Cash Per Share | $0.29 |
Book Value | 136.81M |
Book Value Per Share | 0.32 |
Working Capital | 112.67M |
Cash Flow
In the last 12 months, operating cash flow was -$49.07 million and capital expenditures -$45,000, giving a free cash flow of -$49.12 million.
Operating Cash Flow | -49.07M |
Capital Expenditures | -45,000 |
Free Cash Flow | -49.12M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -26.17% |
FCF Yield | -13.30% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.38% |
Shareholder Yield | -8.38% |
Analyst Forecast
The average price target for MNMD is $5.48, which is 526.79% higher than the current price. The consensus rating is "Buy".
Price Target | $5.48 |
Price Target Difference | 526.79% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Stock Splits
The last stock split was on February 28, 2020. It was a reverse split with a ratio of 1:8.
Last Split Date | Feb 28, 2020 |
Split Type | Reverse |
Split Ratio | 1:8 |